Relationship between metabolic syndrome components in patients with resistant arterial hypertension
KeywordsMetabolic syndrome, resistant arterial hypertension, interconnection
Metabolic syndrome (MS) is a complex of interrelated pathological conditions based on insulin resistance, obesity, dyslipoproteinemia, arterial hypertension (AH). MS is a predictor of the cardiovascular disease, type 2 diabetes mellitus (DM), cancer and premature death. The incidence of type 2 diabetes increases with age and is 25.2% among the elderly. The prevalence of prediabetes or metabolic syndrome was approximately three times higher. Heart failure is another important cause of morbidity and mortality from the cardiovascular disease. Recent studies have shown that the incidence of hospitalizations for heart failure (adjusted for age and gender) was twice as high in patients with diabetes compared with patients without diabetes. Patients with hypertension and abdominal obesity (AO) have an increased risk of various complications: type 2 diabetes -5-9 times, stroke - 7 times, coronary heart disease - 4 times and mortality - 2 times. Objective: To analyze the relationship between the components of the metabolic syndrome in patients with resistant arterial hypertension (RAH). Materials and methods. A retrospective analysis of case histories of 120 patients, including 52 men (43.33%) and 68 women (56.67%) with a diagnosis of RAH and signs of MS. The presence of concomitant pathology, the level of office arterial pressure, pulse pressure (PP) were calculated; body weight, height with calculation of body mass index (BMI); waist circumference (WC), the levels of low-density lipoprotein (LDL) and high-density lipoprotein (HDL), triglycerides (TG), and plasma glucose were studied. Student's criterion was used to assess the degree of significance of the differences, p≤0.05 was taken as the critical level of significance. Pearson's correlation coefficient was used. Disorders of carbohydrate metabolism among patients with MS and RAH is 67.50%, of which type 2 diabetes makes 50.83%, impaired glucose tolerance - 16.67%. Patients with impaired carbohydrate metabolism are 2 times more likely to have complications of hypertension and lower HDL. Women with MS and RAH were significantly older than men and more often had concomitant pathology: morbid obesity (p <0.05), type 2 diabetes mellitus (p <0.05), chronic cerebral ischemia (p <0.05), higher body mass index (p <0.01). Strong correlation between WC and BMI (r = 0.707; p˂0.001), weak direct correlations between WC and PP (r = 0.231; p˂0.05) and WC and TG (r = 0.221; p˂0.05), weak feedback between WC and age (r = -0.188; p˂0.05), and for men direct correlations between WC and TG were confirmed (r = 0.454; p˂0.001), BMI and TG (r = 0.454, p˂0.002).
Medved VI. Metabolicheskij sindrom: vzgljad terapevta [Internet].2020 [Citirovano 2021 ijun' 25]. Dostupno s: https://health-ua.com/article/50215-metabolicheskij-sindrom-vzglyad-terapevta
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018 Feb 26;20(2):12. doi: 10.1007/s11906-018-0812-z
Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43 (Suppl. 1):S111-S134. Diabetes Care. 2020 Aug;43(8):1977-78. doi: 10.2337/dc20-ad08
Williams B, Mancia G, Spiering W, Agabiti RE, Azizi M, Burnier M [et al.]. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
Shu-Zhong Jiang, Wen Lu, Xue-Feng Zong, Hong-Yun Ruan, Yi Liu. Obesity and hypertension (Review).Exp Ther Med. 2016 Oct;12(4):2395-99. doi: 10.3892/etm.2016.3667
Jordan J, Yumuk V, Schlaich M, Nilsson PM, Zahorska-Markiewicz B, Grassi G [et al.]. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens. 2012 Jun;30(6):1047-55. doi: 10.1097/HJH.0b013e3283537347
Mіtchenko YeІ. Metabolіchnyy syndrom, dіabet і sertsevo-sudynnі zakhvoryuvannya [Internet].[Tsitirovano 2021 iyun' 25]. Dostupno s: https://compendium.com.ua/clinical-guidelines/cardiology/section-4/glava-4-metabolicheskij-sindrom-diabet-i-serdechno-sosudistye-zabolevaniya/
Arterial'na hipertenziya. Onovlena ta adaptovana klinichna nastanova, zasnovana na dokazah [Internet]. Nakaz Ministerstva okhorony zdorovya Ukrai'ny vid 24.05.2012 r. No 384. [Cytyrovano 2021 iyun' 25]. Dostupno s: https://www.apteka.ua/article/151151
Nedogoda SV, Barykina IN, Chalyabi TA, Butrina LV, Brel' UA, Mazina GV, Podol'skaya EA. Ozhirenie i arterial'naya gipertenziya. Chast' II: osobennosti antigipertenzivnoy terapii pri ozhirenii. Kardiovaskulyar. terapiya i profilaktika. 2009;8(1):88-98.
How to Cite
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 207
Number of citations: 0